Antibody Current Events | Antibody News | 11
|
| Page
11 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
Researchers at UT Southwestern Medical Center have developed a simple and inexpensive method to screen small synthetic molecules and pull out a handful that might treat cancer and other diseases less expensively than current methods. view more (2008-04-07)
First human study confirms that immune cells can be a primary cause of bone loss in gum disease
Researchers at The Forsyth Institute have confirmed in human gingival tissue that immune cells play a destructive role in periodontal disease. view more (2006-08-28)
Experimental vaccine protects mice against deadly 1918 flu virus
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. view more (2006-10-18)
New research shows how chronic stress worsens neurodegenerative disease course
The evidence is accumulating on how bad stress is for health. Chronic stress can intensify inflammation and increase a person's risk for developing central nervous system infections, neurodegenerative diseases, like multiple sclerosis (MS), and other inflammatory diseases. view more (2007-08-20)
New method monitors early sign of oxidative stress in cancer
The growth of cancerous tumors is fueled, at least in part, by the buildup of free radicals-highly reactive oxygen-containing molecules. view more (2009-09-14)
Heparin antibodies may pose risk in heart surgery patients
New research suggests that patients who develop antibodies to the anti-clotting drug heparin nearly double their risk of death or serious complication after heart surgery. view more (2005-12-05)
UC Davis researchers report new molecule that targets leukemia and lymphoma cells
UC Davis Cancer Center researchers have developed a novel peptide that binds to the surface of leukemia and lymphoma cells with extremely high affinity, specificity and stability, and demonstrates remarkable promise as a tool to help image tumors and deliver anti-cancer drugs. view more (2006-06-13)
Winter- and spring-onset RA patients have worse 6 month outcomes than those with summer onset
When a patient's first symptoms of rheumatoid arthritis (RA) occur in winter, the severity of their RA (as measured by the modified Total Sharp Score, mTSS, an assessment of erosion and joint space narrowing) was rated more severe at six months, when compared to patients whose RA first became symptomatic in summer (Odds Ratio (OR) =2.82 [1.14;7],... view more... (2009-06-12)
Human antibodies protect mice from avian flu
An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an... view more... (2007-05-29)
Scripps research scientists engineer new type of vaccination that provides instant immunity
The experiments, thus far performed only in mice, appear to overcome a major drawback of vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against a pathogen. view more (2009-03-03)
Influenza vaccine causes weaker immune response for children of rural Gabon than in semi-urban areas
Researchers have found that vaccination against influenza strains seem to be more effective in a semi-urban population than in a rural population of schoolchildren in Gabon, Africa, according to an article in the Journal of Infectious Diseases, published by the University of Chicago Press in partnership with the Infectious Diseases Society of... view more... (2007-10-23)
New vaccine stimulates colorectal cancer patient's immune systems to fight cancerous cells
British researchers have developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells. view more (2006-11-15)
Effective Alzheimer treatment: The nose knows
Alzheimer disease (AD) is the most common form of senile dementia, with no effective treatment available. In a study appearing online on August 11 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation. view more (2005-08-12)
Chemoradioimmunotherapy for advanced breast cancer: hope for the future?
Innsbruck, Austria: A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital, Athens, Greece at the 18th Meeting of the European Association for Cancer Research today... view more... (2004-07-06)
Engineered protein effective against Staphylococcus aureus toxin
A research team led by the University of Illinois has developed a treatment for exposure to enterotoxin B, a noxious substance produced by the Staphylococcus aureus bacterium. view more (2007-05-22)
Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail." view more (2008-07-25)
'Intrabody' can mop up mutant protein in Huntington's disease model
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's. view more (2008-05-27)
Researchers discover strategy for predicting the immunity of vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict the immunity of a vaccine without exposing individuals to infection. view more (2008-11-24)
UGA study explains peaks and troughs of dengue epidemics
Scientists have long known that epidemics of dengue fever wax and wane over a period of several years, but they've never been quite sure why. view more (2006-07-31)
Painless 'microneedle' patch may take the sting out of shots
Good news for people fearful of needles and squeamish of shots: Scientists at the 238th National Meeting of the American Chemical Society report the design of a painless patch that may someday render hypodermic needles - as well as annual flu shots - a thing of the past. view more (2009-08-19)
|
|
| Page
11 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
|
